New Delhi: Cognota Healthcare On Monday announced that the United States Food and Drug Administration (U.S FDA) has approved the company blood pressure The monitor device- ‘COGNOHEALTH Blood Pressure Monitor’ marks the company’s successful entry into the medical devices segment.
Regulatory approval is an important milestone for Cognota which can now export its blood pressure monitor devices to the US, Europe and other foreign countries and tap the growing Indian market.
Sanjeev Dahiwadkar, Founder and CEO, Cognota Healthcare said, “Hypertension is a serious health problem across the globe given the current lifestyle and expectations of the people. This silent killer disease is also a major problem after diabetes in India. Therefore, the US FDA approval of the ‘COGNOHEALTH Blood Pressure Monitor’ device is a major leap in Cognota’s efforts to meet this challenge. Built in-house by our R&D team, this approval also proves Cognota’s expertise in successful integration of digital applications with advanced hardware components.
